Tseng, Hung Fu http://orcid.org/0000-0001-6184-6534
Ackerson, Bradley K. http://orcid.org/0000-0002-0816-7345
Sy, Lina S. http://orcid.org/0000-0003-2762-9266
Tubert, Julia E.
Luo, Yi http://orcid.org/0000-0001-8990-2470
Qiu, Sijia
Lee, Gina S. http://orcid.org/0000-0002-7554-9116
Bruxvoort, Katia J. http://orcid.org/0000-0001-8277-2431
Ku, Jennifer H.
Florea, Ana http://orcid.org/0000-0003-0030-8737
Takhar, Harpreet S.
Bathala, Radha
Zhou, Cindy Ke
Esposito, Daina B.
Marks, Morgan A.
Anderson, Evan J. http://orcid.org/0000-0002-1576-4420
Talarico, Carla A.
Qian, Lei
Funding for this research was provided by:
Moderna, Inc.
Article History
Received: 26 May 2023
Accepted: 7 September 2023
First Online: 20 September 2023
Competing interests
: H.F.T., B.K.A., L.S.S., J.E.T., Y.L., S.Q., G.S.L., J.H.K., A.F., H.S.T., R.B., and L.Q. are employees of Kaiser Permanente Southern California, which has been contracted by Moderna to conduct this study. K.J.B. is an adjunct investigator at Kaiser Permanente Southern California. C.K.Z., D.E., M.A.M., and E.J.A. are employees of and shareholders in Moderna, Inc. C.A.T. was an employee of and a shareholder in Moderna, Inc. at the time of analysis conception; C.A.T. is currently an employee of AstraZeneca. H.F.T. received funding from GlaxoSmithKline unrelated to this manuscript; H.F.T. also served on advisory boards for Janssen and Pfizer. B.K.A. received funding from GlaxoSmithKline, Dynavax, Genentech, and Pfizer unrelated to this manuscript. L.S.S. received funding from GlaxoSmithKline and Dynavax unrelated to this manuscript. J.E.T. received funding from Pfizer unrelated to this manuscript. Y.L. received funding from GlaxoSmithKline and Pfizer unrelated to this manuscript. S.Q. received funding from Dynavax unrelated to this manuscript. G.S.L. received funding from GlaxoSmithKline unrelated to this manuscript. K.J.B. received funding from GlaxoSmithKline, Dynavax, Pfizer, and Gilead unrelated to this manuscript. J.H.K. received funding from GlaxoSmithKline unrelated to this manuscript. A.F. received funding from Pfizer, GlaxoSmithKline, and Gilead unrelated to this manuscript. H.S.T. received funding from GlaxoSmithKline, Pfizer, ALK, and Wellcome unrelated to this manuscript. R.B. received funding from GlaxoSmithKline unrelated to this manuscript. L.Q. received funding from GlaxoSmithKline and Dynavax unrelated to this manuscript.